The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...

In January, a new Idaho law will take effect requiring reform of business practices by pharmacy middlemen — in search of ...

The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...

FTC sues top PBMs for inflating insulin prices, accusing them of rigging competition and hurting patients. Legal action also includes GPOs.

The FTC in a statement said one PBM Vice President acknowledged the strategy allowed the Big Three to continue to “drink down ...

In a statement, the FTC wrote that an executive at a PBM acknowledged this strategy for insulins, saying that the big three PBMs continue to “drink down the tasty … rebates.” PBMs pushed back Friday ...

Her time at the FTC has frustrated dealmakers from San Francisco to New York, who have experienced a relative drought of activity in recent years. Democratic donors on Wall Street will likely keep ...

After that, he offers tips about getting a gas credit card and the best way to choose which one to apply for. After the break, Herb goes over an FTC lawsuit against CarShield and what that could mean ...

However, the Federal Trade Commission (FTC) staff has issued a report that focuses on those income claims made by 70 MLM companies. In the report, the FTC staff found many issues with the income ...

With Medicare open enrollment starting next month, the National Community Pharmacists Association is pushing the Centers for Medicare & Medicaid Services to issue fair and common-sense contracting ...

For example, CVS Caremark — the largest PBM with 34% market share, according to the Federal Trade Commission (FTC) — is part of the CVS Health Corporation, which also includes the company’s ...

The FTC voted unanimously to ban fake reviews, such as those generated with AI technology, and other misleading advertising practices. This includes banning marketers from paying for positive or ...